2,709
Views
24
CrossRef citations to date
0
Altmetric
Back Matter

Overexpression of microRNA-155 enhances the efficacy of dendritic cell vaccine against breast cancer

, , , , , , , , , & show all
Article: 1724761 | Received 24 Apr 2019, Accepted 21 Nov 2019, Published online: 09 Feb 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Raquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, Daniel M Borras, Jannes Govaerts, Stefan Naulaerts, Zwi N Berneman, Benoit Beuselinck, Kalijn F Bol, Jannie Borst, an Coosemans, Angeliki Datsi, Jitka Fučíková, Lisa Kinget, Bart Neyns, Gerty Schreibelt, Evelien Smits, Rüdiger V Sorg, Radek Spisek, Kris Thielemans, Sandra Tuyaerts, Steven De Vleeschouwer, I Jolanda M de Vries, Yanling Xiao & Abhishek D Garg. (2022) Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. OncoImmunology 11:1.
Read now

Articles from other publishers (23)

Haider Yahya Jaber & Angham Jasim Mohmmed Ali. Evaluation of serum micro 155 in breast cancer. Evaluation of serum micro 155 in breast cancer.
Zhenghui Jing, Yanfeng Li, Jinxiao Song & Xinlong Zang. (2023) Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes. International Journal of Biological Macromolecules 253, pages 126912.
Crossref
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid & Moein Ala. (2023) Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome. Biomedicine & Pharmacotherapy 165, pages 115104.
Crossref
Murad Alahdal & Eyad Elkord. (2023) Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. Clinical and Translational Medicine 13:9.
Crossref
Mohd Iskandar Jumat, Maria E Sarmiento, Armando Acosta & Kai Ling Chin. (2023) Role of non-coding RNAs in tuberculosis and their potential for clinical applications. Journal of Applied Microbiology 134:6.
Crossref
Nisreen Al-Moghrabi, Maram Al-Showimi, Nujoud Al-Yousef & Lamya AlOtai. (2023) MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers. International Journal of Molecular Sciences 24:10, pages 9021.
Crossref
Johnson Hoang, Pooria Tajalli, Mina Omidiyan, Maria D. Marquez, Orawan Khantamat, Wirote Tuntiwechapikul, Chien-Hung Li, Arati Kohlhatkar, Hung-Vu Tran, Preethi H. Gunaratne & T. Randall Lee. (2023) Self-Assembled Monolayers Derived from Positively Charged Adsorbates on Plasmonic Substrates for MicroRNA Delivery: A Review. Journal of Nanotheranostics 4:2, pages 171-200.
Crossref
Jianjian Wang, Shuang Li, Tianfeng Wang, Si Xu, Xu Wang, Xiaotong Kong, Xiaoyu Lu, Huixue Zhang, Lifang Li, Meng Feng, Shangwei Ning & Lihua Wang. (2023) RNA2Immune: A Database of Experimentally Supported Data Linking Non-Coding RNA Regulation to the Immune System. Genomics, Proteomics & Bioinformatics 21:2, pages 283-291.
Crossref
Kazuki Sumiya, Hiroto Izumi & Kazuo Sakurai. (2023) Enhanced Therapeutic Efficacy of Immunostimulatory CpG-ODN by Silencing SOCS-1 with Polysaccharide/miR-155 Complexes. ACS Applied Bio Materials 6:2, pages 774-783.
Crossref
Lishen Ren, Dongrui Guo, Xiaohui Wan & Rongfeng Qu. (2022) EYA2 upregulates miR-93 to promote tumorigenesis of breast cancer by targeting and inhibiting the STING signaling pathway. Carcinogenesis 43:12, pages 1121-1130.
Crossref
Karolina Hanusek, Jakub Karczmarski, Anna Litwiniuk, Katarzyna Urbańska, Filip Ambrozkiewicz, Andrzej Kwiatkowski, Lidia Martyńska, Anita Domańska, Wojciech Bik & Agnieszka Paziewska. (2022) Obesity as a Risk Factor for Breast Cancer—The Role of miRNA. International Journal of Molecular Sciences 23:24, pages 15683.
Crossref
Wang-Dong Xu, Si-Yu Feng & An-Fang Huang. (2022) Role of miR-155 in inflammatory autoimmune diseases: a comprehensive review. Inflammation Research 71:12, pages 1501-1517.
Crossref
Katerina Kalkusova, Pavla Taborska, Dmitry Stakheev & Daniel Smrz. (2022) The Role of miR-155 in Antitumor Immunity. Cancers 14:21, pages 5414.
Crossref
Sierra J. McDonald, Taryn L. Cranford, Brandon N. VanderVeen, Thomas D. Cardaci, Kandy T. Velázquez, Reilly T. Enos, Ioulia Chatzistamou, Daping Fan & E. Angela Murphy. (2022) miR155 deficiency reduces breast tumor burden in the MMTV-PyMT mouse model. Physiological Genomics 54:11, pages 433-442.
Crossref
Junfeng Wang, Quanyi Wang, Yinan Guan, Yulu Sun, Xiaozhi Wang, Kaylie Lively, Yuzhen Wang, Ming Luo, Julian A. Kim, E. Angela Murphy, Yongzhong Yao, Guoshuai Cai & Daping Fan. (2022) Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function. Journal of Clinical Investigation 132:19.
Crossref
Eric Malekos & Susan Carpenter. (2022) Short open reading frame genes in innate immunity: from discovery to characterization. Trends in Immunology 43:9, pages 741-756.
Crossref
Priya Mondal, Bhavjot Kaur, Jagadish Natesh & Syed Musthapa Meeran. (2022) The emerging role of miRNA in the perturbation of tumor immune microenvironment in chemoresistance: Therapeutic implications. Seminars in Cell & Developmental Biology 124, pages 99-113.
Crossref
Suliman Khan, Anwarul Hasan, Farnoosh Attar, Mohammad Mahdi Nejadi Babadaei, Hojjat Alizadeh Zeinabad, Majid Salehi, Morteza Alizadeh, Mahbub Hassan, Hossein Derakhshankhah, Michael R. Hamblin, Qian Bai, Majid Sharifi, Mojtaba Falahati & Timo L.M. ten Hagen. (2021) Diagnostic and drug release systems based on microneedle arrays in breast cancer therapy. Journal of Controlled Release 338, pages 341-357.
Crossref
Giulia Cosentino, Ilaria Plantamura, Elda Tagliabue, Marilena V. Iorio & Alessandra Cataldo. (2021) Breast Cancer Drug Resistance: Overcoming the Challenge by Capitalizing on MicroRNA and Tumor Microenvironment Interplay. Cancers 13:15, pages 3691.
Crossref
Sanjay Varikuti, Chaitenya Verma, Gayathri Natarajan, Steve Oghumu & Abhay R. Satoskar. (2021) MicroRNA155 Plays a Critical Role in the Pathogenesis of Cutaneous Leishmania major Infection by Promoting a Th2 Response and Attenuating Dendritic Cell Activity. The American Journal of Pathology 191:5, pages 809-816.
Crossref
Sunil Kumar, Muhammad Umer Ashraf, Anil Kumar & Yong-Soo Bae. (2021) Therapeutic Potential of microRNA Against Th2-associated Immune Disorders. Current Topics in Medicinal Chemistry 21:8, pages 753-766.
Crossref
Yong Li, Wei Sun, Fatma Saaoud, Yuzhen Wang, Quanyi Wang, Johnie Hodge, Yvonne Hui, Sophia Yin, Susan M. Lessner, Xiangqing Kong & Daping Fan. (2020) MiR155 modulates vascular calcification by regulating Akt‐FOXO3a signalling and apoptosis in vascular smooth muscle cells. Journal of Cellular and Molecular Medicine 25:1, pages 535-548.
Crossref
Benjamin Gordon & Vijayakrishna K. Gadi. (2020) The Role of the Tumor Microenvironment in Developing Successful Therapeutic and Secondary Prophylactic Breast Cancer Vaccines. Vaccines 8:3, pages 529.
Crossref